The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating o ...

They additionally found that each additional sleep disruption correlated with a 0.006 cubic centimeter increase in ...

The gross proceeds to the Company from the offering are expected to be approximately $3.5 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The ...

Honda and Nissan begin merger talks with a plan for the combination to be completed in 2026, Qualcomm scores a victory in its ...

Eli Lilly (LLY) advanced over +1% in pre-market trading after the FDA approved the company’s weight-loss drug Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity.

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Lilly’s Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.

A few light rain chances return into Christmas Day. Meteorologist Dillon Gaudet has the latest in your full ABC 36 Storm Team ...